SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001062993-20-001283
Filing Date
2020-03-09
Accepted
2020-03-06 20:01:00
Documents
3
Group Members
EQUINE CHARTER PRIVATE EQUITY FUND DCCCLXXXVIII, LLCEQUINE CHARTER PRIVATE EQUITY FUND VII, LLCEQUINE CHARTER PRIVATE EQUITY FUND XIEQUINE CHARTER PRIVATE EQUITY FUND XIIEQUINE CHARTER PRIVATE EQUITY FUND XVEQUINE CHARTER PRIVATE EQUITY FUND XXEQUINE HOLD

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D/A formsc13da.htm SC 13D/A 349787
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 26723
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 5702
  Complete submission text file 0001062993-20-001283.txt   384134
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Subject) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-89519 | Film No.: 20696300
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5000 RIVERSIDE DR STE100E IRVING TX 75039
Business Address
Atwood Brent (Filed by) CIK: 0001753747 (see all company filings)

Type: SC 13D/A